Alpha Tau Medical (DRTS) Other Non-Current Assets (2020 - 2026)
Alpha Tau Medical's (DRTS) quarterly Other Non-Current Assets came in at $462000.0 in Q1 2026, up 5.24% year-on-year from $439000.0 in Q1 2025, and down 3.55% quarter-over-quarter from $479000.0 in Q4 2025.
Alpha Tau Medical (DRTS) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Alpha Tau Medical has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $462000.0 for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $462000.0, up 5.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $462000.0 (up 5.24% YoY), and the FY2025 annual result was $479000.0, up 10.88% from the prior year.
- Other Non-Current Assets came in at $462000.0 for Q1 2026 at Alpha Tau Medical, down from $479000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $223.0 million in Q1 2022 to a low of $207000.0 in Q2 2022.
- The 5-year median for Other Non-Current Assets is $441000.0 (2023), against an average of $13.5 million.
- Peak annual rise in Other Non-Current Assets reached 113.04% in 2023, while the deepest fall reached 99.8% in 2023.
- Alpha Tau Medical's Other Non-Current Assets stood at $391000.0 in 2022, then increased by 20.46% to $471000.0 in 2023, then fell by 8.28% to $432000.0 in 2024, then climbed by 10.88% to $479000.0 in 2025, then retreated by 3.55% to $462000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $462000.0 (Q1 2026), $479000.0 (Q4 2025), and $472000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - | 462,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 462,000.00 |
| Dec 31, 2025 | 479,000.00 |
| Sep 30, 2025 | 472,000.00 |
| Jun 30, 2025 | 463,000.00 |
| Mar 31, 2025 | 439,000.00 |
| Dec 31, 2024 | 432,000.00 |
| Sep 30, 2024 | 438,000.00 |
| Jun 30, 2024 | 437,000.00 |
| Mar 31, 2024 | 465,000.00 |
| Dec 31, 2023 | 471,000.00 |
| Sep 30, 2023 | 441,000.00 |
| Jun 30, 2023 | 441,000.00 |
| Mar 31, 2023 | 441,000.00 |
| Dec 31, 2022 | 391,000.00 |
| Sep 30, 2022 | 393,000.00 |
| Jun 30, 2022 | 207,000.00 |
| Mar 31, 2022 | 223.00 Mn |
| Dec 31, 2021 | 2.03 Mn |
| Dec 31, 2020 | 139,000.00 |